Public health professionals are expressing serious apprehension regarding President-elect Donald Trump’s decision to nominate Robert F. Kennedy Jr. as the head of the Department of Health and Human Services (HHS). Known for his controversial views on vaccines and a history of disseminating medical misinformation, Kennedy’s leadership could significantly undermine health policy and scientific integrity in the United States.
Lawrence Gostin, director of the O’Neill Institute for National and Global Health Law at Georgetown University, voiced his concerns, stating, “I can’t recall a more troubling moment for public health and scientific integrity than the election of Donald Trump and the nomination of Robert F. Kennedy Jr. as secretary of health.”
He elaborated, “Claiming that RFK Jr. is unqualified would be an understatement. The individual in charge of HHS should be committed to science and evidence, yet he has made a career out of eroding public confidence in health initiatives.”
If confirmed, Kennedy would be responsible for overseeing pivotal health organizations such as the U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA), both under the HHS umbrella. Following the conclusion of his independent presidential campaign, Kennedy endorsed Trump for the 2024 election and introduced a health initiative titled “Make America Healthy Again,” which addresses chronic diseases, food additives, and environmental toxins.
Despite his focus on certain health issues, Kennedy has faced backlash for perpetuating falsehoods, including the debunked assertion that vaccines cause autism. Extensive studies have consistently proven the safety and effectiveness of vaccines. Furthermore, his opposition to fluoride in drinking water—a practice recognized for its role in preventing dental problems—has been linked to various unfounded health fears. He has also claimed that the FDA is blocking access to raw milk, despite the agency’s warnings regarding its potential health hazards.
Read More: What Donald Trump’s Win Could Mean for Vaccines
Kennedy has assured the public that neither he nor the Trump Administration would remove vaccines from the market. However, experts remain concerned that he may appoint individuals to the FDA or CDC who share his skepticism toward vaccines, which could delay vaccine approvals. Gostin noted that while there are safeguards to prevent radical policy shifts, Kennedy could still wield influence by selectively presenting data that calls vaccine safety into question, ultimately diminishing public trust and potentially leading to an uptick in vaccine-preventable illnesses.
Gostin cautioned that “cherry-picked” information from HHS could mislead the public, fostering a climate of distrust in established health guidelines. He articulated a significant worry: “If agencies like the FDA and CDC distribute misleading information, the consequences for public health could be dire, resulting in decreased vaccination rates and a resurgence of diseases like measles and mumps.”
“A vaccine skeptic should not lead our country’s most vital health agencies,” he asserted. “Kennedy has consistently positioned himself outside the established scientific consensus, spreading misinformation that could threaten public health.”
Dr. Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia and a former advisor for the CDC and FDA, expressed his astonishment at the nomination. He compared the situation to appointing someone who questions the laws of gravity to head NASA, criticizing Kennedy for suggesting that infectious diseases should receive less focus in NIH research.
“With an H5N1 bird flu outbreak currently underway, cutting funding for infectious disease research seems imprudent,” commented Katelyn Jetelina, an epidemiologist and founder of the newsletter Your Local Epidemiologist.
While Kennedy may face a difficult confirmation process in the Senate, Offit pointed out that the mere nomination highlights a concerning trend regarding public trust in science. Experts are apprehensive that Kennedy’s potential leadership could further perpetuate the spread of medical misinformation.
Jetelina expressed her concerns: “There’s a significant chance that misinformation could stem from such a powerful position, leading to public confusion and raising doubts among those seeking science-based health information. My greatest fear is that disinformation could transition from fringe beliefs into mainstream narratives.”
Although some public health experts are cautiously optimistic about Kennedy’s views on nutrition and food safety, they remain skeptical of his overall effectiveness. He advocates for banning harmful food additives, aligning with growing concerns about the national nutrition crisis. Dr. Dariush Mozaffarian, director of the Food Is Medicine Institute at Tufts University, acknowledges the potential in Kennedy’s focus on nutrition but is wary of the broader implications for public health.
“I’m hopeful yet hesitant to judge RFK Jr. solely based on his past actions and statements,” Mozaffarian commented. “My hope is that he will prioritize sound science in his approach.”
Nevertheless, following Trump’s announcement, numerous public health experts are left feeling disheartened by the potential ramifications of Kennedy’s leadership at HHS. Gostin succinctly captured the prevailing sentiment: “In short, he’s unlikely to prioritize science, and rather than making America healthier, he may contribute to a further decline in public confidence in health policies.”
